Tegafur-gimeracil-oteracil potassium (TS-1) is an oral anticancer agent composed of Tegafur , Gimeracil (HY-17469), and Oteracil potassium (HY-17511) at a molar ratio of 1:0.4:1. TS-1 can be utilized in research on the peritoneal dissemination of gastric cancer[1].